Skip to content
Hybrid~4 wks to decision Source verified 2026-11-05

Annals of Oncology

Published by European Society for Medical Oncology (ESMO) / Elsevier

Official journal of ESMO covering systemic cancer therapy, immuno-oncology, precision oncology, and phase I–III clinical trials.

Core Submission Checklist & Author Requirements

  • Structured abstract (Background, Patients and methods, Results, Conclusions) and Highlights bullets
  • Clinical trial registration number in abstract
  • CONSORT 2025 or REMARK biomarker reporting checklist

Submission Requirements by Article Type

Original Research Specifications

Main manuscript text excluding references and supplementary material.

Main Text Limit

3,500 words

Abstract Cap

300 words

Displays (Figures & Tables)

Max 6

Peer Review Model

Single-blind

Reporting Guidelines

CONSORT 2025 or REMARK biomarker reporting checklist

Ensure manuscript adheres to the appropriate EQUATOR Network guideline.

AI Writing & Image Policy

Authors must disclose the use of generative AI tools in the Methods or Acknowledgments. AI cannot be credited as an author; humans retain full accountability.

Figure policy: Human review mandatory

Publishing Fees / APC: No submission fee; hybrid open access option available

Data verified from official publisher guidelines at https://www.annalsofoncology.org/content/authorinfo